A potent antagonist of protease-activated receptor 2 that inhibits multiple signalling functions in human cancer cells.

A potent antagonist of protease-activated receptor 2 that inhibits multiple signalling functions in human cancer cells.

  • Post by:
  • 22 May 2019
  • Comments off
Categories:

Participating Institutions

The University of Queensland
The University of Sydney
Australian National University
Monash University
Queensland University of Technology
Edith Cowan University
CSIRO

International Partners

Boston Children’s Hospital, Harvard
University of Washington
University of Tokyo
Massachusetts Institute of Technology
University of Illinois at Urbana-Champaign
University of Southampton

Twitter
YouTube